Austin Health Research Online

Geoff Harley

View Statistics Email Alert RSS Feed

Claim profile

Loading... 2 0 20 0 false

Credit Name

Geoff Harley

Full Name

Harley, Geoff

Department

Nephrology

Loading... 3 0 20 0 false

Results 1-5 of 5 (Search time: 0.005 seconds).

Refman/EndNote EndNote Bibtex RefWorks Excel CSV Send via email

	Publication Year	Title	Author(s)
1	2023	Mutation of regulatory phosphorylation sites in PFKFB2 does not affect the anti-fibrotic effect of metformin in the kidney.	Harley, Geoff ; Katerelos, Marina ; Gleich, Kurt; Lee, Mardiana ; Mount, Peter F ; Power, David A
2	1-Sep-2022	Blocking AMPK signalling to acetyl-CoA carboxylase increases cisplatin-induced acute kidney injury and suppresses the benefit of metformin.	Harley, Geoff ; Katerelos, Marina ; Gleich, Kurt; de Souza, David P; Narayana, Vinod K; Kemp, Bruce E; Power, David A ; Mount, Peter F
3	3-Sep-2020	Mutation of regulatory phosphorylation sites in PFKFB2 worsens renal fibrosis.	Lee, Mardiana ; Harley, Geoff ; Katerelos, Marina ; Gleich, Kurt; Sullivan, Mitchell A; Laskowski, Adrienne; Coughlan, Melinda; Fraser, Scott A; Mount, Peter F ; Power, David A
4	Jul-2018	Use of a new end-stage kidney disease risk calculator in the Kidney Disease Improving Global Outcomes guideline to evaluate the impact of different living kidney donor candidate assessments.	Lee, Darren; Manzoor, Momena; Harley, Geoff ; Whitlam, John B ; Cook, Natasha ; Choy, Suet-Wan ; Sandiford, Megan ; Gibson, Charlotte; McMahon, Lawrence P; Roberts, Matthew A
5	Jan-2018	Lifetime end-stage kidney disease risk estimation in living kidney donor candidates remains a challenge	Lee, Darren; Whitlam, John B ; Cook, Natasha ; Manzoor, Momena; Harley, Geoff ; Choy, Suet-wan; McMahon, Lawrence P; Roberts, Matthew A